Clinical data, real-world studies,
and health economic analyses of Apligraf®.
Apligraf is backed by extensive, reliable, and unmatched clinical and real-world evidence in both VLUs and DFUs.1-7
Only Apligraf has conducted randomized controlled trials (RCTs) resulting in FDA approval for the healing of VLUs and DFUs.1,5,7Clinical trials
Examine real-world observational studies that prove Apligraf closes more VLUs and DFUs faster.Real-world evidence
Health economic analyses
See how Apligraf has been shown to reduce VLU and DFU burden on patients and healthcare costs.Health economic studies
Support for you and your practice
See how Organogenesis' Circle of Care can help with reimbursement support and more, or contact an Organogenesis Tissue Regeneration Specialist about how Apligraf can help your patients.Contact us
Please refer to the Apligraf Package Insert for complete prescribing information.
- Apligraf [package insert]. Canton, MA: Organogenesis Inc; 2017.
- Marston WA, et al. Wound Repair Regen. 2014;22(3):334-340.
- Treadwell T, et al. Adv Wound Care. 2018;7(3):69-76.
- Sabolinski ML, et al. J Comp Eff Res. 2018;7(8):797-805.
- Veves A, et al. Diabetes Care. 2001;24(2):290-295.
- Kirsner RS, et al. Wound Repair Regen. 2015;23(5):737-744.
- Data on file. Organogenesis Inc.